title: High dose aprotinin reduces prothrombin and fibrinogen conversion in patients undergoing extracorporeal circulation for myocardial revascularization.
authors.forename: M
authors.initials: M
authors.lastname: Spannagl
authors.forename: W
authors.initials: W
authors.lastname: Dietrich
authors.forename: A
authors.initials: A
authors.lastname: Beck
authors.forename: W
authors.initials: W
authors.lastname: Schramm
mesh_terms: D007611:Aprotinin / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005112:Extracorporeal Circulation; D005340:Fibrinogen / Q000187:drug effects*; D006801:Humans; D008297:Male; D009204:Myocardial Revascularization / Q000379:methods*; D011516:Prothrombin / Q000187:drug effects*
chemical_list: D011516:Prothrombin; D005340:Fibrinogen; D007611:Aprotinin